Abstract:AIM:To investigate the expression of B7-H1 in human colorectal carcinoma (CRC) to define its regulating effects on T cells in tumor microenvironment.METHODS:One hundred and two paraffin blocks and 33 fresh samples of CRC tissues were subject to this study. Immunohistochemistry was performed for B7-H1 and CD3 staining in CRC tissues. Ficoll-Hypaque density gradient centrifugation was used to isolate peripheral blood mononuclear cells of fresh CRC tissues; flow cytometry and immunofluorescence staining were used for detection of regulatory T cells. Data was analyzed with statistical software.RESULTS:Costimulatory molecule B7-H1 was found strongly expressed in CRC tissues, localized in tumor cell membrane and cytoplasm, while weak or none expression of B7-H1 was detected in pared normal colorectal tissues. Meanwhile, CD3 positive T cells were found congregated in CRC tumor nest and stroma. Statistic analysis showed that B7-H1 expression level was negatively correlated to the total T cell density in tumor nest (P < 0.0001) and tumor stroma (P = 0.0200) of 102 cases of CRC tissues. Among the total T cells, a variable amount of regulatory T cells with a clear Foxp3⁺ (forkhead box P3) staining could be detected in CRC tissues and patients' blood. Interestingly, in the 33 samples (15 cases of B7-H1(high) CRC tissues and 18 cases of B7-H1(low) CRC tissues) of freshly isolated mononuclear cells from CRC tissues, the percentages of CD4⁺Foxp3⁺ and CD8⁺Foxp3⁺ regulatory T cells were found remarkably higher in B7-H1(high) CRC tissues than in B7-H1(low) CRC tissues (P = 0.0024, P = 0.0182), indicating that B7-H1 expression was involved in proliferation of regulatory T cell. No significant difference was found in CRC peripheral blood (P = 0.0863, P = 0.0678). PD-1 is the specific ligand for B7-H1 pathway transferring inhibitory signal to T cell, which is expressed by activated T cell. Our further analysis of PD-1 expression on T cells in CRC tissues showed that conventional T cells (CD4⁺Foxp3⁻/CD8⁺Foxp3⁻), which was thought to contribute to the anti-tumor immune response, highly expressed PD-1; while regulatory T cells (CD4⁺Foxp3⁺/CD8⁺Foxp3⁻) almost failed to express PD-1. The average percentage of PD-1 expression on regulatory T cells was significantly higher than the percentage of PD-1 on conventional T cells (CD4⁺Foxp3⁻ T cell, P < 0.0001; CD8⁺Foxp3⁻ T cell, P < 0.0001). The diverse expression of PD-1 might lead to different fate of T cell subsets in B7-H1 over-expression CRC tumor microenvironment.CONCLUSION:B7-H1 expression in tumor cells can inhibit the conventional T cell proliferation in tumor microenvironment through the PD-1 expression on conventional T cells.

B7-H5 Blockade Enhances CD8+ T-cell-mediated Antitumor Immunity in Colorectal Cancer

B7-H1 Expression is Associated with Expansion of Regulatory T Cells in Colorectal Carcinoma

Overexpression of B7-H4 is Associated with Infiltrating Immune Cells and Poor Prognosis in Metastatic Colorectal Cancer.

Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis

Clinical Significance and Regulation of the Costimulatory Molecule B7-H3 in Human Colorectal Carcinoma

Expression of B7-H2 on CD8+ T cells in colorectal cancer microenvironment and its clinical significance

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells

B7-H3 Inhibits the IFN-γ-dependent Cytotoxicity of Vγ9Vδ2 T Cells Against Colon Cancer Cells

Expression and Clinical Significance of B7-H4 in Human Colorectal Carcinoma and the Tumor Microenvironment

B7-H1 Expression is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

Selective Blockade of B7‐H3 Enhances Antitumour Immune Activity by Reducing Immature Myeloid Cells in Head and Neck Squamous Cell Carcinoma

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

[Expression Characteristics and Clinical Significance of B7-H3 in Colorectal Cancer].

B7-H3 Regulates KIF15-activated ERK1/2 Pathway and Contributes to Radioresistance in Colorectal Cancer.

B7-H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1α

B7-H4 Induces Epithelial-Mesenchymal Transition and Promotes Colorectal Cancer Stemness

B7 Blockade Alters the Balance Between Regulatory T Cells and Tumor-Reactive T Cells for Immunotherapy of Cancer

The Role of B7-H3 in Tumors and Its Potential in Clinical Application.

B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2

Potential Therapeutic Targets of B7 Family in Colorectal Cancer